These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 16973340

  • 1. Binding of STW 5 (Iberogast) and its components to intestinal 5-HT, muscarinic M3, and opioid receptors.
    Simmen U, Kelber O, Okpanyi SN, Jaeggi R, Bueter B, Weiser D.
    Phytomedicine; 2006; 13 Suppl 5():51-5. PubMed ID: 16973340
    [Abstract] [Full Text] [Related]

  • 2. STW 5 (Iberogast) and its individual herbal components modulate intestinal electrophysiology of mice.
    Sibaev A, Yuece B, Kelber O, Weiser D, Schirra J, Göke B, Allescher HD, Storr M.
    Phytomedicine; 2006; 13 Suppl 5():80-9. PubMed ID: 16713219
    [Abstract] [Full Text] [Related]

  • 3. Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum.
    Schemann M, Michel K, Zeller F, Hohenester B, Rühl A.
    Phytomedicine; 2006; 13 Suppl 5():90-9. PubMed ID: 16765572
    [Abstract] [Full Text] [Related]

  • 4. Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle.
    Ammon HP, Kelber O, Okpanyi SN.
    Phytomedicine; 2006; 13 Suppl 5():67-74. PubMed ID: 16978852
    [Abstract] [Full Text] [Related]

  • 5. [A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study].
    Madisch A, Melderis H, Mayr G, Sassin I, Hotz J.
    Z Gastroenterol; 2001 Jul; 39(7):511-7. PubMed ID: 11505331
    [Abstract] [Full Text] [Related]

  • 6. STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine.
    Müller MH, Liu CY, Glatzle J, Weiser D, Kelber O, Enck P, Grundy D, Kreis ME.
    Phytomedicine; 2006 Jul; 13 Suppl 5():100-6. PubMed ID: 16713220
    [Abstract] [Full Text] [Related]

  • 7. Radical scavenging and anti-inflammatory properties of STW 5 (Iberogast) and its components.
    Schempp H, Weiser D, Kelber O, Elstner EF.
    Phytomedicine; 2006 Jul; 13 Suppl 5():36-44. PubMed ID: 16777393
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms involved in the gastro-protective effect of STW 5 (Iberogast) and its components against ulcers and rebound acidity.
    Khayyal MT, Seif-El-Nasr M, El-Ghazaly MA, Okpanyi SN, Kelber O, Weiser D.
    Phytomedicine; 2006 Jul; 13 Suppl 5():56-66. PubMed ID: 16963243
    [Abstract] [Full Text] [Related]

  • 9. The multi-herbal drug STW 5 (Iberogast) has prosecretory action in the human intestine.
    Krueger D, Gruber L, Buhner S, Zeller F, Langer R, Seidl S, Michel K, Schemann M.
    Neurogastroenterol Motil; 2009 Nov; 21(11):1203-e110. PubMed ID: 19210628
    [Abstract] [Full Text] [Related]

  • 10. Ex vivo/in vitro absorption of STW 5 (Iberogast) and its extract components.
    Kelber O, Wittwer A, Lapke C, Kroll U, Weiser D, Okpanyi SN, Heilmann J.
    Phytomedicine; 2006 Nov; 13 Suppl 5():107-13. PubMed ID: 16920344
    [Abstract] [Full Text] [Related]

  • 11. Extracts from peppermint leaves, lemon balm leaves and in particular angelica roots mimic the pro-secretory action of the herbal preparation STW 5 in the human intestine.
    Allam S, Krueger D, Demir IE, Ceyhan G, Zeller F, Schemann M.
    Phytomedicine; 2015 Nov 15; 22(12):1063-70. PubMed ID: 26547528
    [Abstract] [Full Text] [Related]

  • 12. The herbal preparation STW 5 (Iberogast) desensitizes intestinal afferents in the rat small intestine.
    Liu CY, Müller MH, Glatzle J, Weiser D, Kelber O, Enck P, Grundy D, Kreis ME.
    Neurogastroenterol Motil; 2004 Dec 15; 16(6):759-64. PubMed ID: 15601426
    [Abstract] [Full Text] [Related]

  • 13. Intestinal spasmolytic effects of STW 5 (Iberogast) and its components.
    Heinle H, Hagelauer D, Pascht U, Kelber O, Weiser D.
    Phytomedicine; 2006 Dec 15; 13 Suppl 5():75-9. PubMed ID: 16709451
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of inflammation-induced alterations in rat small intestine by the herbal preparations STW 5 and STW 6.
    Michael S, Kelber O, Hauschildt S, Spanel-Borowski K, Nieber K.
    Phytomedicine; 2009 Mar 15; 16(2-3):161-71. PubMed ID: 19196500
    [Abstract] [Full Text] [Related]

  • 15. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast).
    Melzer J, Rösch W, Reichling J, Brignoli R, Saller R.
    Aliment Pharmacol Ther; 2004 Dec 15; 20(11-12):1279-87. PubMed ID: 15606389
    [Abstract] [Full Text] [Related]

  • 16. Affinity of Iresine herbstii and Brugmansia arborea extracts on different cerebral receptors.
    Nencini C, Cavallo F, Bruni G, Capasso A, De Feo V, De Martino L, Giorgi G, Micheli L.
    J Ethnopharmacol; 2006 May 24; 105(3):352-7. PubMed ID: 16406412
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mechanisms of the anti-proliferative and anti-inflammatory effects of the herbal fixed combination STW 5 (Iberogast®) on colon adenocarcinoma (HT29) cells in vitro.
    Bonaterra GA, Kelber O, Weiser D, Kinscherf R.
    Phytomedicine; 2013 Jun 15; 20(8-9):691-8. PubMed ID: 23535188
    [Abstract] [Full Text] [Related]

  • 20. The active components and the pharmacological multi-target principle of STW 5 (Iberogast).
    Wegener T, Wagner H.
    Phytomedicine; 2006 Jun 15; 13 Suppl 5():20-35. PubMed ID: 16926095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.